# Candan Karabagli > Candan Karabagli is a seed investor at GS Yuasa (The Hague) backing Biotechnology and Analytics. See 6 investments, check sizes, portfolio. Updated Aug 2026. - Type: Angel Investor - Fund: [GS Yuasa](https://shizune.co/investors/profile/gs-yuasa) - Location: The Hague, The Netherlands - Total investments: 6 - Last investment: Mar 2024 - Lead investor: 0% - Last updated: Aug 2026 - LinkedIn: https://www.linkedin.com/in/candan-karabagli-9b811b6 Candan Karabagli is a seed investor at GS Yuasa in The Hague focused on Biotechnology and Analytics. Candan Karabagli - Yönetim Kurulu Başkanı, CHAIRMAN @ GS Yuasa ## Round sizes | Stage | Round size | | --- | --- | | Seed | $280k–$1.1M | ## Investment focus ### Industry | Industry | Investments | Share | | --- | --- | --- | | Biotechnology | 2 | 33% | | Analytics | 1 | 17% | | Biopharma | 1 | 17% | | Life Science | 1 | 17% | | Manufacturing | 1 | 17% | 10 industries tracked in total. ### Stage | Stage | Investments | Share | | --- | --- | --- | | Seed | 2 | 33% | | Angel | 1 | 17% | | Series A | 1 | 17% | | Funding Round | 1 | 17% | ## Investments | Company | Description | Amount | Stage | Date | Website | | --- | --- | --- | --- | --- | --- | | PhiTech Bioinformatics | PhiTech Bioinformatics translates genome-wide molecular data, Transcriptomics, Epigenomics, Microbiomics into biotechnology solutions. | $1.1M | Seed | Mar 08, 2024 | | | PhiTech Bioinformatics | PhiTech Bioinformatics translates genome-wide molecular data, Transcriptomics, Epigenomics, Microbiomics into biotechnology solutions. | $280K | | Mar 22, 2023 | | | PhiTech Bioinformatics | PhiTech Bioinformatics translates genome-wide molecular data, Transcriptomics, Epigenomics, Microbiomics into biotechnology solutions. | $280K | Angel | Mar 22, 2023 | | | PhiTech Bioinformatics | PhiTech Bioinformatics translates genome-wide molecular data, Transcriptomics, Epigenomics, Microbiomics into biotechnology solutions. | $280K | Seed | Mar 22, 2023 | | | Biolive | BIOLIVE was founded as a start-up company in Incubation Centre at Istanbul Technical University in 2016. The company transitioned to becoming a corporation with an investment from Vestel Ventures, a subsidiary of Zorlu Holding in 2017. Currently, the company produces bioplastic raw materials such as Bio-PE, Bio-PP, and Bio-ABS in scale-up andnext-gen materials such as plant-based leather and also offers sustainable solutions. | | Series A | Mar 02, 2020 | | | Vispera | Vispera is an image recognition and analytics company that runs its proprietary technology. With that, we provide retailers and suppliers with the missing insights they need for better performance at all points of sale. The image recognition based automation we provide helps our clients monitor the performance of their in-store execution and takecorrective actions.Our business technology solutions have been shaped into products that help boost productivity for field operations and improve in-store performance of display units. We provide real-time data and guidance on the field team performance, as well as key retail execution metrics such as on-shelf availability, planogram compliance, shelf share, price tag readings, branding material visibility, etc. Among these metrics, problems with on-shelf-availability alone cost the retail sector 1.75 Trillion USD each year. Delivering and commoditizing IR services require expert knowledge which we have. Due to our high performance in accuracy, reporting dashboard flexibility and customer satisfaction we are recently seeing competitors’ clients convert to Vispera services. We maintain our technological edge as well as a robust but flexible product strategy.We want to make image recognition a commodity service for the global retail sector and enable perfect store execution and experience for retailers, suppliers and consumers alike. As such, we progressively move from an IR vendor into retail data analytics provider supported by IR-based evidential reality. | $950K | Seed | Feb 15, 2016 | | 6 of 6 investments shown. ## Co-investors - [Istcapital](https://shizune.co/investors/profile/istcapital) — VC Fund, 3 deals together - [Omurga Capital](https://shizune.co/investors/profile/omurga-gayrimenkul-portf%C3%B6y) — VC Fund, 2 deals together - [Vestel Ventures](https://shizune.co/investors/profile/vestel-ventures) — VC Fund, 2 deals together - [212](https://shizune.co/investors/profile/212-capital-partners) — VC Fund, 1 deal together - [Alchemist Accelerator](https://shizune.co/investors/profile/alchemist-accelerator) — VC Fund, 1 deal together - [Arya GSYF](https://shizune.co/investors/profile/arya-gsyf) — VC Fund, 1 deal together ## About GS Yuasa VC Fund 1 contacts available at GS Yuasa. | Name | Title | Profile | | --- | --- | --- | | Candan Karabagli | Yönetim Kurulu Başkanı, CHAIRMAN | https://shizune.co/investors/profile/candan-karabagli | ## Similar investors ### Similar industry - [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund - [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund - [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund ### Similar stage - [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund - [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund - [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund ### Similar country - [Alesta Yatırım](https://shizune.co/investors/profile/alesta-girisim) — VC Fund - [APY Ventures](https://shizune.co/investors/profile/apy-ventures) — VC Fund - [Boğaziçi Ventures](https://shizune.co/investors/profile/bo%C4%9Fazi%C3%A7i-ventures) — VC Fund ## Featured in investor lists - [All Angel Investors in Turkey](https://shizune.co/investors/angel-investors-turkey) - [Biotechnology Angel Investors in Turkey](https://shizune.co/investors/biotechnology-angel-investors-turkey) - [Biotech Angel Investors in Middle East](https://shizune.co/investors/biotech-angel-investors-middle-east) - [Biotech Angel Investors in Turkey](https://shizune.co/investors/biotech-angel-investors-turkey) - [Biotechnology Investors in Middle East](https://shizune.co/investors/biotechnology-investors-middle-east) - [Biotech Investors in Middle East](https://shizune.co/investors/biotech-investors-middle-east) ## FAQ ### What does Candan Karabagli invest in? Candan Karabagli invests primarily in Biotechnology, Analytics and Biopharma startups, most often at Seed and Angel stage. Most of the 6 investments tracked by Shizune back companies in Turkey. The Investment Focus section breaks down every industry, stage and country in the portfolio. ### What is Candan Karabagli's check size? Candan Karabagli typically joins rounds of $280k–$1.1M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Candan Karabagli participates in. ### When did Candan Karabagli last invest? The most recent investment recorded for Candan Karabagli closed in Mar 2024. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly. ### Is Shizune's investor data accurate? Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page. # About Shizune Shizune.co is an investor database. Core features: - 48,091 startup investors (angels, VCs, accelerators, and others) - Email, phone, LinkedIn (for intros), socials, and other contact data - Updated daily from public funding news - CSV and Excel export The User can access the full database FOR FREE after signing up: shizune.co